Drug Type Small molecule drug |
Synonyms Neomycin Sulfate/Bacitracin, BIVATRACIN, Baramycin + [1] |
Target |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (31 Oct 1956), |
Regulation- |
Molecular FormulaC23H46N6O13 |
InChIKeyPGBHMTALBVVCIT-VCIWKGPPSA-N |
CAS Registry119-04-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Non-complicated skin and skin structure infection | JP | 31 Oct 1956 | |
Odour body | JP | 31 Oct 1956 | |
Pyoderma | JP | 31 Oct 1956 | |
Secondary infection | JP | 31 Oct 1956 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemodialysis complication | Phase 3 | EG | 10 Apr 2023 | |
Infection of hemodialysis catheter | Phase 3 | EG | 10 Apr 2023 |